Cherry Chan, FIA, Partner at Barnett Waddingham takes a look back at the insurance actuarial and risk issues that dominated 2015 and consider what might be in store in 2016. Is Solvency II all wrapped up? After much anticipation Solvency II is finally here…and it’s here to stay. So, can we finally rejoice and sit back knowing that Europe’s insurance policyholders can sleep more soundly at night?
Well, not quite. Late 2015 brought good news for the 19 firms that received full or partial model approval. Firms also got to grips with approval for  Long Term Guarantees and transitional applications, which were particularly important for certain lines of business.
In addition, higher category firms participated in the (mostly) successful prep phase reporting. For most it was an epic and hazardous but, ultimately, triumphant journey. However, we’ll have to wait for the ‘all live happily ever after’ ending to the story - for now at least.
For example, every major model change will need re-approval, some firms need to make changes before they can use the Matching Adjustment, and firms need to address differences between live and prep phase reporting.
So the SII tale continues into 2016…
Which aspects of Solvency II should receive some more TLC in 2016?
• A similar number of firms are expected to go through the IMAP and MA approval this year. While lessons will no doubt have been learnt from the first round of approvals firms and the PRA have recently communicated their reflections on the IMAP process, firms should not expect an easy ride but they should hopefully have clearer expectations of what is required.
• Standard formula firms will have working calculation models by now. If your firm hasn’t got a solution in place then you might be starting to feel the panic set in (or contacting us for help). Joking aside, many firms will be looking to automate/streamline data collection and improve their models and reporting processes in 2016 to try to control costs yet comply with all the ‘not so simple’ rules.
• 2016 will be the year that firms can assess whether the risk and governance frameworks they have put in place are fit for purpose. Many may have taken a strict interpretation of the rules and put in place a structure that in reality is hard to embed and not adding value. In particular all firms will have been through at least one round of the ORSA by now. It’s time to embed the process and make the ORSA useful to the board and wider business rather than just ‘ticking the box’ (see our ORSA blog). Another area will be the validation cycle. It is widely recognised that going forward validation needs to be more efficient and effective and to develop a cycle that will add value rather than be a process just to get regulatory approval.
• Balance sheet optimisation will now be a focus as the new regime is in place. One area firms may want to look at is the diversification benefits between market and other risks.
Is 2016 all about Solvency II?
Of course not, for example, conduct and cyber risk will remain on the supervisors’ radar, Britain’s possible exit from the EU should not be ignored and individual firms or sectors will have their own issues to address. However, Solvency II will still dominate.
We know it might be slightly depressing and many may want to move on, but it will take a number of years for Solvency II to embed into BAU and be truly effective.
In 2016 we will have to tackle similar themes to those at the fore in 2015, but it isn’t quite déjà vu as the areas of focus have changed. Additionally, those firms that have limited contact with the PRA in recent years should be prepared for increased interaction as PRA focus switches from implementing regulations to supervising.
In any event, we will have plenty to keep us occupied over the next twelve months and there is a great deal of work that can be done for our industry to get real value from Solvency II in 2016.
|
